ACO NAME AND LOCATION

Independent Physicians ACO, LLC
325 Broad Street
Sumter, South Carolina 29150

ACO PRIMARY CONTACT

Primary Contact Name Rob Bramlett
Primary Contact Phone Number 615-967-6687
-Primary Contact Email Address Rob.bramlett@visualizehealth.co

 

ORGANIZATIONAL INFORMATION

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Colonial Family Practice, LLC N
Synergy Physician Group P.A. N
South Carolina Internal Medicine Associates and Rehabilitation, L.L.C N
R Dale Padgett Md Pa New Corp N

 

ACO governing body:

Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Lowder Clayton Board Member 1 ACO Participant Representative Colonial Family Practice, LLC
Leonard Jason Board Member 1 ACO Participant Representative Colonial Family Practice, LLC
Lucas Luke Board Member 1 ACO Participant Representative Colonial Family Practice, LLC
Piccione Ron Medicare Beneficiary Representative 1 Medicare Beneficiary Representative N/A

 

Key ACO clinical and administrative leadership:

Rob Bramblett ACO Executive
Clayton Lowder Medical Director
Ken Persaud Compliance Officer
Ken Persaud Quality Assurance/Improvement Officer

 

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Clinical Committee Clayton Lowder, MD
Compliance Committee Ken Persaud, MD
Executive Committee Thomas Watson
Financial Committee Rob Bramblett

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

SHARED SAVINGS AND LOSSES

Amount of Shared Savings/Losses

  • N/A

Shared Savings Distribution

  • N/A

QUALITY PERFORMANCE RESULTS

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 79.9
ACO-2 CAHPS: How Well Your Providers Communicate N/A 92.63
ACO-3 CAHPS: Patients' Rating of Provider N/A 91.93
ACO-4 CAHPS: Access to Specialists N/A 83.52
ACO-5 CAHPS: Health Promotion and Education N/A 60
ACO-6 CAHPS: Shared Decision Making N/A 75.28
ACO-7 CAHPS: Health Status/Functional Status N/A 71.82
ACO-34 CAHPS: Stewardship of Patient Resources N/A 27.52
ACO-8 Risk-Standardized, All Condition Readmission N/A 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented N/A 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

PAYMENT RULE WAIVERS

·         No, our ACO does not use the SNF 3-Day Rule Waiver.

 

For general questions or additional information about Accountable Care Organizations, please visit www.cms.gov and do a search using that term, or call 1-800 MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048